HER2-positive breast cancer resistance to trastuzumab is associated with metabolic switch

Authors :: Tomasz J. Sarnowski
R. Dubianski
M. Leszczynski
S. Kubala
R. Konopinski
Natalia Rusetska
W. Olszewski
Elzbieta Sarnowska
Zbigniew Nowecki
Janusz A. Siedlecki
Agnieszka Jagiełło-Gruszfeld
Source :: Annals of Oncology. 29:viii5
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.

Subjects :: Oncology
medicine.medical_specialty
Trastuzumab
business.industry
HER2 Positive Breast Cancer
Internal medicine
medicine
Hematology
business
medicine.drug

Full Text Access

Tools